BACKGROUND: Evidence on the relative costs and effects of interventions that do not consider 'real-world' constraints on implementation may be misleading. However, in many low- and middle-income countries, time and data scarcity mean that incorporating health system constraints in priority setting can be challenging. METHODS: We developed a 'proof of concept' method to empirically estimate health system constraints for inclusion in model-based economic evaluations, using intensified case-finding strategies (ICF) for tuberculosis (TB) in South Africa as an example. As part of a strategic planning process, we quantified the resources (fiscal and human) needed to scale up different ICF strategies (cough triage and WHO symptom screening). We id...
OBJECTIVE: Cost functions linked to transmission dynamic models are commonly used to estimate the re...
Global guidelines for new technologies are based on cost and efficacy data from a limited number of ...
Approximately 85% of tuberculosis (TB) related deaths occur in low- and middle-income countries wher...
Abstract Background Evidence on the relative costs and effects of interventions that do not consider...
Mathematical models are increasingly being used to compare strategies for tuberculosis (TB) control ...
OBJECTIVES: Health systems face nonfinancial constraints that can influence the opportunity cost of ...
Priority setting for infectious disease control has evolved beyond simple descriptions of costs and ...
Health system constraints are increasingly recognized as an important addition to model-based analys...
Global guidelines for new technologies are based on cost and efficacy data from a limited number of ...
Background The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by ...
BACKGROUND: The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by ...
Background: Limited evidence for the implementation of new health technologies in low- and middle-in...
Objectives: Existing evidence suggests that drug-resistant tuberculosis (DR-TB) remains a huge publi...
INTRODUCTION: Nosocomial Mycobacterium tuberculosis (Mtb) transmission substantially impacts health ...
Health economists, national decision-makers and global health specialists have been interested in ca...
OBJECTIVE: Cost functions linked to transmission dynamic models are commonly used to estimate the re...
Global guidelines for new technologies are based on cost and efficacy data from a limited number of ...
Approximately 85% of tuberculosis (TB) related deaths occur in low- and middle-income countries wher...
Abstract Background Evidence on the relative costs and effects of interventions that do not consider...
Mathematical models are increasingly being used to compare strategies for tuberculosis (TB) control ...
OBJECTIVES: Health systems face nonfinancial constraints that can influence the opportunity cost of ...
Priority setting for infectious disease control has evolved beyond simple descriptions of costs and ...
Health system constraints are increasingly recognized as an important addition to model-based analys...
Global guidelines for new technologies are based on cost and efficacy data from a limited number of ...
Background The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by ...
BACKGROUND: The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by ...
Background: Limited evidence for the implementation of new health technologies in low- and middle-in...
Objectives: Existing evidence suggests that drug-resistant tuberculosis (DR-TB) remains a huge publi...
INTRODUCTION: Nosocomial Mycobacterium tuberculosis (Mtb) transmission substantially impacts health ...
Health economists, national decision-makers and global health specialists have been interested in ca...
OBJECTIVE: Cost functions linked to transmission dynamic models are commonly used to estimate the re...
Global guidelines for new technologies are based on cost and efficacy data from a limited number of ...
Approximately 85% of tuberculosis (TB) related deaths occur in low- and middle-income countries wher...